Department of Pathology
Johns Hopkins Medicine
The mission of the Department of Pathology is to discover, disseminate and apply knowledge in the study of disease, to advance the field of human health, and to provide the highest quality of patient care.
For Patients
Do you need a second opinion on your pathology diagnosis? Our expert pathologists can help assure you have the most accurate diagnosis.
Second Opinions
For Clinicians
The Johns Hopkins Medical Laboratory provides world-recognized expertise in Surgical Pathology and Cytopathology consultation.
Consultation ServicesFind Faculty & Staff
Latest News
Congratulations, Dr. Anne Le!
Feb 21, 2020
Hopkins Pathology #1 in NIH Funding for 2019
Feb 6, 2020
Congratulations, Denis Wirtz!
Jan 24, 2020
Education at Johns Hopkins Pathology
From web-based microscope unknown slide conferences to brilliantly illustrated and interactive iPad applications, our faculty educate at home and across the globe. Our diverse students are trained to become the next generation of medical and scientific leaders.
Recent Publications
Our department's impact on pathology research is evident: Johns Hopkins Pathology has been the #1 NIH-funded pathology department for 11 of the past 12 years. Below are recent highlighted publications from our department.
'Off-the-Shelf' Alternative to Speed Bone Repair
Xu J, Wang Y, Hsu CY, Gao Y, Meyers CA, Chang L, Zhang L, Broderick K, Ding C, Peault B, Witwer K, James AW.
Read full article
'Off-the-Shelf' Alternative to Speed Bone Repair
Faculty Bio
Xu J, Wang Y, Hsu CY, Gao Y, Meyers CA, Chang L, Zhang L, Broderick K, Ding C, Peault B, Witwer K, James AW.
Cancer Clues Retrieved from Rapid-Autopsy Research
Duregon E, Schneider J, DeMarzo AM, Hooper JE. Rapid research autopsy is a stealthy but growing contributor to cancer research. Cancer 2019 Sep;125(17):2915-9.
Read full article
Cancer Clues Retrieved from Rapid-Autopsy Research
Faculty Bio
Duregon E, Schneider J, DeMarzo AM, Hooper JE. Rapid research autopsy is a stealthy but growing contributor to cancer research. Cancer 2019 Sep;125(17):2915-9.
Shedding New Light on ARID1A Deficient Tumors
Park Y, Chui MH, Suryo Rahmanto Y, Yu ZC, Shamanna RA, Bellani MA, Gaillard S, Ayhan A, Viswanathan A, Seidman MM, Franco S, Leung AKL, Bohr VA, Shih IM, Wang TL. Loss of ARID1A in tumor cells renders selective vulnerability to combined ionizing radiation and PARP inhibitor therapy. Clin Cancer Res 2019 Sep 15;25(18):5584-94.
Read full article
Shedding New Light on ARID1A Deficient Tumors
Faculty Bio
Park Y, Chui MH, Suryo Rahmanto Y, Yu ZC, Shamanna RA, Bellani MA, Gaillard S, Ayhan A, Viswanathan A, Seidman MM, Franco S, Leung AKL, Bohr VA, Shih IM, Wang TL. Loss of ARID1A in tumor cells renders selective vulnerability to combined ionizing radiation and PARP inhibitor therapy. Clin Cancer Res 2019 Sep 15;25(18):5584-94.
Unique Molecular Profile Discovered in Intraductal Prostate Cancer
Khani F, Wobker SE, Hicks JL, Robinson BD, Barbieri CE, De Marzo AM, Epstein JI, Pritchard CC, Lotan TL. Intraductal carcinoma of the prostate in the absence of high-grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutations. J Pathol 2019 Sep;249(1):79-89.
Read full article
Unique Molecular Profile Discovered in Intraductal Prostate Cancer
Faculty Bio
Khani F, Wobker SE, Hicks JL, Robinson BD, Barbieri CE, De Marzo AM, Epstein JI, Pritchard CC, Lotan TL. Intraductal carcinoma of the prostate in the absence of high-grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutations. J Pathol 2019 Sep;249(1):79-89.
Grand Rounds
Each Monday at 8:30 am, the Department of Pathology hosts a series of speakers to discuss advancements in the field of disease diagnosis and treatment.
Next Session
Molecular Classification to Precision Therapies in CNS Embryonal Tumors - Jeffrey Rubens, M.D.
View session details